충남대학교외국학술지지원센터

글로벌메뉴

  • HOME
  • sitemap

주메뉴

CNU Search

전체 ㅣ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ㅣ 가 나 다 라 마 바 사 아 자 차 카 타 파 하 기타
검색 타입
상세검색
검색어[가나다ABC : 전체]
총 24건 중 24건 출력
1/2 페이지 엑셀파일 출력

검색간략리스트

열거형 테이블형
검색리스트 테이블
No 자료
유형		 서명 저자 발행처 원문제공시작년 수록
매체
1 저널기사 Acute Gastrointestinal Bleeding/ 미리보기
Fallah, Marc A Saunders 2000
2 저널기사 Advances in Diagnostic and Therapeutic Endoscopy/ 미리보기
Mallery, Shawn Saunders 2000
3 저널기사 Advances in Inflammatory Bowel Disease/ 미리보기
Stotland, Brian R Saunders 2000
4 저널기사 Antibiotic Resistance - Antibiotic resistance is agent specific, and is not related to volume or duration of use nor limited to certain antibiotic classes. Antibiotics should be viewed as having little or no resistance potential or having a high resistance potential. Antibiotics with a low resistance potential should not be restricted but those with a high resistance potential should be restricted. The only effective mechanism to control antibiotic resistance is by limiting hospital formularies to include only antibiotics with little or no resistance potential. Physicians in the ambulatory setting need to be more selective in antibiotic prescribing and preferentially select antibiotics with a low resistance potential./ 미리보기
Cunha, Burke A Saunders 2000
5 저널기사 Antibiotic Synergy and Antagonism - This article discusses some current problems in antibacterial combination therapy, including methods of laboratory testing for synergistic effect of antibiotic combinations, synergy and antagonism of known mechanisms as studied in experimental models, and antibiotic combinations available commercially. The author also examines clinical situations where a therapeutic benefit can be expected by prescribing a combination of antibiotics./ 미리보기
Acar, Jacques F Saunders 2000
6 저널기사 Antienterococcal Antibiotics - The spread of enterococci as a major cause of nosocomial infections and the increasing resistance of these organisms to all currently available antibiotics, including glycopeptides, has rendered therapy of these infections particularly difficult. Mechanisms of resistance to antimicrobial agents are now understood to a significant extent. Therapeutic regimens are often based on the results of experimental studies but most often have not been validated by large clinical trials. The main options for the treatment of infection caused by susceptible and resistant enterococci, using commercially available or new therapeutic agents, are reviewed here./ 미리보기
Lefort, Agnes Saunders 2000
7 저널기사 Antimicrobial Pharmacodynamics - Pharmacodynamics is a science that integrates microbiological and pharmacokinetic data into more clinically relevant relationships. An understanding of pharmacodynamic concepts is essential for the clinician, for it forms the scientific basis for rational antimicrobial chemotherapy. Herein, fundamental pharmacodynamic principles and their application to clinical practice are discussed./ 미리보기
Ambrose, Paul G Saunders 2000
8 저널기사 Clinical use of Fluoroquinolones - The quinolones have undergone a "structural evolution" since the inadvertent discovery of nalidixic acid in 1962. A better understanding of structure-activity and structure-toxicity relationships has allowed chemists to modify the adaptable quinolone structure to enhance or limit the extent of antimicrobial activity and to improve various other product attributes such as the pharmacokinetic profile, tolerability, drug interaction potential, and toxicity of each new agent. Ciprofloxacin and levofloxin/oflofloxin have demonstrated relatively clean safety profiles over several years of clinical use. Newer fluorquinolones should be fully evaluated by clinicians prior to their use so as to avoid potentially life-threatening adverse events. Several newer quinolones are available or are being investigated for clinical use, including gatifloxacin, moxifloxican, clinafloxacin, and gemifloxacin. Rare but life-threatening toxicities (e.g., cardiotoxicity, hepato 미리보기
Owens Jr, Robert C Saunders 2000
9 저널기사 Colorectal Cancer Update: Prevention, Screening, Treatment, and Surveillance for High-Risk Groups/ 미리보기
Bond, John H Saunders 2000
10 저널기사 Constipation/ 미리보기
Wald, Arnold Saunders 2000
11 저널기사 Cumulative Index 2000 /// 미리보기
Saunders 2000
12 저널기사 Diarrhea/ 미리보기
Schiller, Lawrence R Saunders 2000
13 저널기사 Drug-Induced Liver Disease/ 미리보기
Lewis, James H Saunders 2000
14 저널기사 Gastroesophageal Reflux Disease and Barrett's Esophagus/ 미리보기
Katzka, David A Saunders 2000
15 저널기사 Helicobacter Pylori/ 미리보기
Shiotani, Akiko Saunders 2000
16 저널기사 Hepatology in the New Millennium: Advances in Viral Hepatitis, Hepatic Disorders, and Liver Transplantation/ 미리보기
Ramrakhiani, Sanjay Saunders 2000
17 저널기사 Index /// 미리보기
Saunders 2000
18 저널기사 Irritable Bowel Syndrome/ 미리보기
Rothstein, Robin D Saunders 2000
19 저널기사 Monotherapy Versus Combination Therapy for Bacterial Infections - The authors discuss the latest findings regarding the use of one or more antimicrobial drugs for a variety of infections. They offer suggestions for treatment based on a host of considerations, including the synergy and antagonism of specific drugs, type of infection, potential toxicities, and cost./ 미리보기
Bouza, Emilio Saunders 2000
20 저널기사 Nonsteroidal Anti-Inflammatory Drugs/ 미리보기
Tseng, Chi-Chuan Saunders 2000
1 2 
임시보관함보기

하단메뉴